{"id":"research-involving-human-embryos-act-2008","name":"Research Involving Human Embryos Act 2008","slug":"research-involving-human-embryos-act-2008","collection":"act","jurisdiction":"vic","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":173411,"registerId":"vic-research-involving-human-embryos-act-2008-current","compilationNumber":null,"startDate":"2026-04-05","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Research Involving Human Embryos Act 2008","content":"Version No. 005\n\n**Research Involving Human Embryos Act 2008**\n\n**No. 74 of 2008**\n\nVersion incorporating amendments as at  \n22 October 2025\n\n**table of provisions**\n\n*Section Page*\n\nPart 1—Preliminary 1\n\n1 Purpose 1\n\n2 Commencement 1\n\n3 Definitions 1\n\n4 Meaning of excess ART embryo 7\n\n5 Act to bind the Crown 8\n\nPart 2—Offences 9\n\n6 Offence—use of excess ART embryo 9\n\n7 Offence—use of other embryos 10\n\n8 Offence—certain activities involving use of human eggs 11\n\n9 Offence—use of embryo that was created by fertilisation and that is not an excess ART embryo 12\n\n10 Offence—breaching a licence condition 12\n\n11 Person not liable for conduct purportedly authorised 13\n\nPart 3—Licensing of embryo research 14\n\nDivision 1—Embryo Research Licensing Committee of the NHMRC 14\n\n12 Functions of Committee 14\n\n13 Powers of Committee 14\n\nDivision 2—Licensing system 14\n\n14 Person may apply for licence 14\n\n15 Determination of application by Committee 15\n\n16 Notification of decision 17\n\n17 Period of licence 17\n\n18 Licence is subject to conditions 18\n\n19 Variation of licence 20\n\n20 Suspension or revocation of licence 20\n\n21 Surrender of licence 21\n\n22 Notification of variation, suspension or revocation of licence 21\n\nDivision 3—Reporting and confidentiality 21\n\n23 NHMRC Licensing Committee to make certain information publicly available 21\n\n24 Confidential commercial information may only be disclosed in certain circumstances 22\n\nDivision 4—Review provisions 24\n\n25 Meaning of terms 24\n\n26 Review of decisions 26\n\nPart 4—Monitoring powers 27\n\n27 Powers available to inspectors for monitoring compliance 27\n\n28 Monitoring powers 27\n\n29 Power to secure 29\n\n30 Monitoring warrants 29\n\n31 Details of warrant to be given to occupier etc. 31\n\n32 Announcement before entry 31\n\n33 Occupier entitled to be present during search 31\n\n34 Inspector must produce identity card on request 32\n\n35 Consent 32\n\n36 Compensation for damage 32\n\n37 Extended operation of this Part 33\n\nPart 5—General 34\n\n38 Regulations 34\n\nPart 6—Transitional provisions and consequential amendment to other Acts 35\n\nDivision 1—Transitional provisions 35\n\n39 Definitions 35\n\n40 Superseded references 35\n\n41 Existing applications for licences 35\n\n42 Existing licences 35\n\n43 Offences 36\n\n44 Consent 36\n\n45 Donations 36\n\nEndnotes 38\n\n1 General information 38\n\n2 Table of Amendments 40\n\n3 Explanatory details 41\n\n**Version No.** **005**\n\n**Research Involving Human Embryos Act 2008**\n\n**No. 74 of 2008**\n\nVersion incorporating amendments as at  \n22 October 2025\n\n**The Parliament of Victoria enacts:**\n\nPart 1—Preliminary\n\n\t1 Purpose\n\nThe purpose of this Act is to address concerns, including ethical concerns, about scientific developments in relation to human reproduction and the utilisation of human embryos by regulating activities that involve the use of certain human embryos created by assisted reproductive technology or by other means.\n\n\t2 Commencement\n\n(1) This Act comes into operation on a day to be proclaimed.\n\n(2) If this Act does not come into operation before 1 January 2010, it comes into operation on that day.\n\n\t3 Definitions\n\n(1) In this Act—\n\n***accredited ART centre*** means a person or body accredited to carry out assisted reproductive technology by—\n\n(a) the Reproductive Technology Accreditation Committee of the Fertility Society of Australia; or\n\n(b) if the regulations prescribe another body or other bodies in addition to, or instead of, the body mentioned in paragraph (a)—that other body or any of those other bodies, as the case requires;\n\n***AHEC*** means the Australian Health Ethics Committee established by the National Health and Medical Research Council Act 1992 of the Commonwealth;\n\n***animal*** does not include a human;\n\n***assisted reproductive treatment*** has the meaning it has in the **Assisted Reproductive Treatment Act 2008**;\n\n***Authority*** means the Victorian Assisted Reproductive Treatment Authority established under Part 9 of the **Assisted Reproductive Treatment Act 2008**;\n\n***Commonwealth Act*** means the Research Involving Human Embryos Act 2002 of the Commonwealth;\n\n***Commonwealth Authority*** means the following—\n\n(a) a body corporate established for a public purpose by or under a Commonwealth Act;\n\n(b) a company in which a controlling interest is held by any one of the following persons together, or by two or more of the following persons together—\n\n(i) the Commonwealth;\n\n(ii) a body covered by paragraph (a);\n\n(iii) a body covered by either subparagraph (i) or (ii);\n\n***confidential commercial information*** means information that has a commercial or other value that would be, or could reasonably be expected to be, destroyed or diminished if the information were disclosed;\n\n***disclose***, in relation to information, means give or communicate in any way;\n\n***excess ART embryo*** has the meaning given by section 4;\n\n***HREC*** means a Human Research Ethics Committee;\n\n***human embryo*** means a discrete entity that has arisen from either—\n\n(a) the first mitotic division when fertilisation of a human oocyte by a human sperm is complete; or\n\n(b) any other process that initiates organised development of a biological entity with a human nuclear genome that has the potential to develop up to, or beyond, the stage at which the primitive streak appears—\n\nand has not yet reached 8 weeks of development since the first mitotic division;\n\n***human sperm*** includes human spermatids;\n\n***hybrid embryo*** means—\n\n(a) an embryo created by the fertilisation of a human egg by animal sperm; or\n\n(b) an embryo created by the fertilisation of an animal egg by human sperm; or\n\n(c) a human egg into which the nucleus of an animal cell has been introduced; or\n\n(d) an animal egg into which the nucleus of a human cell has been introduced; or\n\n(e) a thing declared by the regulations to be a hybrid embryo;\n\n***inspector*** means a person appointed under section 33(1) of the Commonwealth Act;\n\n***licence*** means a licence issued under section 15;\n\n***NHMRC Licensing Committee*** means the Committee established by section 13 of the Commonwealth Act;\n\n***oocyte*** means an ovum from a woman;\n\n***partner***, in relation to a person, means—\n\n(a) the person's spouse; or\n\n(b) another person who lives with the first person as a couple on a genuine domestic basis, irrespective of gender;\n\n***precursor cell*** means a cell that has the potential to develop into a human egg or human sperm;\n\n***proper consent***, in relation to the use of an excess ART embryo or a human egg, or the creation or use of any other embryo, means consent obtained in accordance with guidelines issued by the Chief Executive Officer of the NHMRC under the National Health and Medical Research Council Act 1992 of the Commonwealth and prescribed by the regulations under the Commonwealth Act for the purposes of the definition of proper consent in section 8 of that Act;\n\n***research*** includes an experimental procedure or clinical trial;\n\n***responsible person*** means—\n\n(a) in relation to an excess ART embryo—\n\n(i) each person who provided the egg or sperm from which the embryo was created; and\n\n(ii) the woman for whom the embryo was created, for the purpose of achieving her pregnancy; and\n\n(iii) any person who was the partner of a person mentioned in subparagraph (i) at the time the egg or sperm mentioned in that paragraph was provided; and\n\n(iv) any person who was the partner of the woman mentioned in subparagraph (ii) at the time the embryo was created; or\n\n(b) in relation to an embryo other than an excess ART embryo—each person whose reproductive material, genetic material or cell was used, or is proposed to be used, in the creation or use of the embryo; or\n\n(c) in relation to a human egg—the woman who was the biological donor of the egg;\n\n***sperm*** means sperm from a man;\n\n***spouse***, in relation to a person, means the person's husband or wife;\n\n***store*** means—\n\n(a) to freeze an oocyte, embryo or sperm; or\n\n(b) to otherwise preserve an oocyte, embryo or sperm by a prescribed method;\n\n***the NHMRC*** means the National Health and Medical Research Council established by the National Health and Medical Research Council Act 1992 of the Commonwealth;\n\n***unsuitable for implantation***, in relation to a human embryo, means a human embryo that—\n\n(a) is diagnosed by pre-implantation genetic diagnosis as unsuitable for implantation, in accordance with the Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and Research (2007), issued by the Chief Executive Officer of the NHMRC; or\n\n(b) is determined to be unsuitable for implantation in the body of a woman, in accordance with objective criteria specified in guidelines issued by the Chief Executive Officer of the NHMRC under the National Health and Medical Research Council Act 1992 of the Commonwealth and prescribed by the regulations under the Commonwealth Act for the purposes of paragraph (b) of the definition of unsuitable for implantation in section 7(1) of that Act;\n\n***use*** includes develop, or development, as the case requires;\n\n***woman*** means a female human.\n\n(2) For the purposes of the definition of ***human embryo*** in subsection (1), in working out the length of the period of development of a human embryo, any period when the development of the embryo is suspended is to be disregarded.\n\n(3) In this Act, a reference to an embryo is a reference to a human embryo, unless the contrary intention appears.\n\n(4) A reference in this Act to an embryo (including a human embryo) is a reference to a living embryo.\n\n(5) A reference in this Act to a human egg is a reference to a human oocyte.\n\n(6) A reference in this Act to a human embryo does not include a reference to—\n\n(a) a hybrid embryo; or\n\n(b) a human embryonic stem cell line.\n\n\t4 Meaning of excess ART embryo\n\n(1) In this Act—\n\n***excess ART embryo*** means a human embryo that—\n\n(a) was created, by assisted reproductive technology, for use in the assisted reproductive treatment of a woman; and\n\n(b) is excess to the needs of—\n\n(i) the woman for whom it was created; and\n\n(ii) her partner (if any) at the time the embryo was created.\n\n(2) For the purposes of paragraph (b) of the definition of ***excess ART embryo***, a human embryo is excess to the needs of the persons mentioned in that paragraph at a particular time if—\n\n(a) each such person has given written authority for use of the embryo for a purpose other than a purpose relating to the assisted reproductive treatment of the woman concerned, and the authority is in force at that time; or\n\n(b) each such person has determined in writing that the embryo is excess to their needs, and the determination is in force at that time.\n\n\t5 Act to bind the Crown\n\n(1) This Act binds the Crown, not only in right of the State of Victoria, but also, so far as the legislative power of the Parliament permits, the Crown in all its other capacities.\n\n(2) Nothing in this Act renders the Crown liable to be prosecuted for an offence.\n\nPart 2—Offences\n\n\t6 Offence—use of excess ART embryo\n\n(1) A person commits an offence if the person intentionally uses an excess ART embryo, unless—\n\n(a) the use by the person is authorised by a licence; or\n\n(b) the use by the person is an exempt use within the meaning of subsection (3).\n\n(2) An offence against subsection (1) is an indictable offence punishable by imprisonment for a term not exceeding 5 years.\n\n(3) A use of an excess ART embryo by a person is an exempt use for the purposes of subsection (1) if—\n\n(a) the use consists only of—\n\n(i) storage of the excess ART embryo; or\n\n(ii) removal of the excess ART embryo from storage; or\n\n(iii) transport of the excess ART embryo; or\n\n(b) the use consists only of observation of the excess ART embryo; or\n\n(c) the use consists only of allowing the excess ART embryo to succumb; or\n\n(d) the use is carried out by an accredited ART centre, and—\n\n(i) the excess ART embryo is not suitable to be placed in the body of the woman for whom it was created where the suitability of the embryo is determined only on the basis of its biological fitness for implantation; and\n\n(ii) the use forms part of diagnostic investigations conducted in connection with the assisted reproductive treatment of the woman for whom the excess ART embryo was created; or\n\n(e) the use is carried out by an accredited ART centre and is for the purposes of achieving pregnancy in a woman other than the woman for whom the excess ART embryo was created; or\n\n(f) the use is of a kind prescribed by the regulations for the purposes of this paragraph.\n\nS. 6(4) amended by No. 68/2009 s. 97(Sch. item 102).\n\n(4) Despite section 72(1) of the **Criminal Procedure Act 2009**, an accused does not bear a burden of presenting or pointing to evidence in accordance with that section in relation to any matter in subsection (1) or (3) of this section.\n\n(5) In subsection (3)—\n\n***diagnostic investigation***, in relation to an excess ART embryo, means any procedure undertaken on embryos for the sole purpose of diagnostic investigations for the direct benefit of the woman for whom it was created;\n\n***observation***, in relation to an excess ART embryo, includes taking a photograph of the embryo, or taking a recording of the embryo from which a visual image can be produced.\n\n\t7 Offence—use of other embryos\n\n(1) A person commits an offence if—\n\n(a) the person intentionally uses an embryo; and\n\n(b) the embryo is—\n\n(i) a human embryo created by a process other than the fertilisation of a human egg by a human sperm; or\n\n(ii) a human embryo created by a process other than the fertilisation of a human egg by a human sperm that contains genetic material provided by more than 2 persons; or\n\n(iii) a human embryo created using precursor cells taken from a human embryo or a human foetus; or\n\n(iv) a hybrid embryo; and\n\n(c) the use by the person is not authorised by a licence.\n\n(2) An offence against subsection (1) is an indictable offence punishable by imprisonment for a term not exceeding 5 years.\n\n**Note**\n\nThe creation or development of embryos mentioned in this section is prohibited under the **Prohibition of Human Cloning for Reproduction Act 2008**, unless authorised by a licence under this Act.\n\n\t8 Offence—certain activities involving use of human eggs\n\n(1) A person commits an offence if—\n\n(a) the person undertakes research or training involving the fertilisation of a human egg by a human sperm up to, but not including, the first mitotic division, outside the body of a woman for the purposes of research or training in ART; and\n\n(b) the person is not authorised by a licence to undertake the research or training.\n\n(2) An offence against subsection (1) is an indictable offence punishable by imprisonment for a term not exceeding 5 years.\n\n\t9 Offence—use of embryo that was created by fertilisation and that is not an excess ART embryo\n\n(1) A person commits an offence if—\n\n(a) the person intentionally uses, outside the body of a woman, a human embryo—\n\n(i) that was created by fertilisation of a human egg by a human sperm; and\n\n(ii) that is not an excess ART embryo; and\n\n(b) the use is not for a purpose relating to the assisted reproductive treatment of a woman carried out by an accredited ART centre, and the person knows or is reckless as to that fact.\n\n(2) An offence against subsection (1) is an indictable offence punishable by imprisonment for a term not exceeding 5 years.\n\n\t10 Offence—breaching a licence condition\n\n(1) A person commits an offence if the person intentionally engages in conduct, knowing that the conduct contravenes a condition of a licence that applies to the person, or reckless as to whether the conduct contravenes a condition of such a licence.\n\n(2) An offence against subsection (1) is an indictable offence punishable by imprisonment for a term not exceeding 5 years.\n\n(3) In this section—\n\n***engage in conduct*** means—\n\n(a) do an act; or\n\n(b) omit to perform an act.\n\n\t11 Person not liable for conduct purportedly authorised\n\n(1) To avoid doubt, a person is not criminally responsible for an offence against this Act in respect of particular conduct if—\n\n(a) the conduct by the person is purportedly authorised by a provision of a licence; and\n\n(b) the licence or the provision is invalid, whether because of a technical defect or irregularity or for any other reason; and\n\n(c) the person did not know, and could not reasonably be expected to have known, of the invalidity of the licence or the provision.\n\n(2) In this section—\n\n***licence*** includes a purported licence.\n\nPart 3—Licensing of embryo research\n\nDivision 1—Embryo Research Licensing Committee of the NHMRC\n\n\t12 Functions of Committee\n\nThe functions of the NHMRC Licensing Committee under this Act are—\n\n(a) to perform functions in relation to licences under Division 2; and\n\n(b) to perform functions in relation to databases under Division 3; and\n\n(c) to perform such other functions as are conferred on it by this Act or any other law.\n\n\t13 Powers of Committee\n\nThe NHMRC Licensing Committee has power to do all things necessary or convenient to be done for or in connection with the performance of its functions under this Act.\n\nDivision 2—Licensing system\n\n\t14 Person may apply for licence\n\n(1) A person may apply to the NHMRC Licensing Committee for a licence authorising one or more of the following—\n\n(a) use of excess ART embryos;\n\n(b) creation of human embryos other than by fertilisation of a human egg by a human sperm, and use of such embryos;\n\n(c) creation of human embryos other than by fertilisation of a human egg by a human sperm that contains genetic material provided by more than 2 persons, and use of such embryos;\n\n(d) creation of human embryos using precursor cells from a human embryo or a human foetus, and use of such embryos;\n\n(e) research and training involving the fertilisation of a human egg by a human sperm up to, but not including, the first mitotic division, outside the body of a woman for the purposes of research or training in ART;\n\n(f) creation of hybrid embryos by the fertilisation of an animal egg by a human sperm, and use of such embryos up to, but not including, the first mitotic division, if—\n\n(i) the creation or use is for the purposes of testing sperm quality; and\n\n(ii) the creation or use will occur in an accredited ART centre.\n\n(2) To avoid doubt, subsection (1)(a), (b), (c) and (d) do not permit the NHMRC Licensing Committee to authorise any use of an excess ART embryo or other embryo that would result in the development of the embryo for a period of more than 14 days, excluding any period when development is suspended.\n\n(3) An application under subsection (1)—\n\n(a) must be made in accordance with the requirements (if any) specified in writing by the NHMRC Licensing Committee; and\n\n(b) must be accompanied by the fee (if any) prescribed by the regulations.\n\n\t15 Determination of application by Committee\n\n(1) This section applies if a person has made an application under section 14 for a licence.\n\n(2) The NHMRC Licensing Committee must decide, in accordance with this section, whether or not to issue the licence.\n\n(3) The NHMRC Licensing Committee must not issue the licence unless it is satisfied of the following—\n\n(a) that appropriate protocols are in place—\n\n(i) to enable proper consent to be obtained before an excess ART embryo or human egg is used, or other embryo is created or used under the licence; and\n\n(ii) to enable compliance with any restrictions on such consent;\n\n(b) that the activity or project proposed in the application has been assessed and approved by a HREC that is constituted in accordance with, and acting in compliance with, the NHMRC National Statement on Ethical Conduct in Human Research (2007), as in force from time to time.\n\n(4) In deciding whether to issue the licence, the NHMRC Licensing Committee must have regard to the following—\n\n(a) restricting the number of excess ART embryos, other embryos or human eggs to that likely to be necessary to achieve the goals of the activity or project proposed in the application;\n\n(b) the likelihood of significant advance in knowledge or improvement in technologies for treatment as a result of the use of excess ART embryos or human eggs, or the creation or use of other embryos, proposed in the application, which could not reasonably be achieved by other means;\n\n(c) any relevant guidelines, or relevant parts of guidelines, issued by the NHMRC under the National Health and Medical Research Council Act 1992 of the Commonwealth and prescribed by the regulations under the Commonwealth Act for the purposes of section 21(4)(c) of that Act;\n\n(d) the HREC assessment of the application mentioned in subsection (3)(b);\n\n(e) such additional matters (if any) as are prescribed by the regulations.\n\n\t16 Notification of decision\n\n(1) The NHMRC Licensing Committee must notify its decision on an application for a licence under section 15 to the following—\n\n(a) the applicant;\n\n(b) the HREC that assessed and approved the activity or project proposed in the application as mentioned in section 15(3)(b);\n\n(c) the Authority.\n\n(2) If the NHMRC Licensing Committee decides to issue the licence, it must, in addition to issuing the licence to the applicant, give a copy of the licence to the bodies mentioned in subsection (1)(b) and (c).\n\n\t17 Period of licence\n\n(1) A licence—\n\n(a) comes into force on the day specified in the licence, or if no day is specified, on the day on which it is issued; and\n\n(b) remains in force until the day specified in the licence, unless it is suspended, revoked or surrendered before that day.\n\n(2) A licence is not in force throughout any period of suspension.\n\n\t18 Licence is subject to conditions\n\n(1) A licence is subject to the condition that before an excess ART embryo or human egg is used, or any other embryo is created or used, as authorised by the licence—\n\n(a) each responsible person in relation to the excess ART embryo, human egg or other embryo must have given proper consent to that creation or use; and\n\n(b) the licence holder must have reported in writing to the NHMRC Licensing Committee that such consent has been obtained, and any restrictions to which the consent is subject.\n\n(2) A licence is subject to the condition that the use of an excess ART embryo or human egg, or the creation or use of any other embryo, must be in accordance with any restrictions to which the proper consent under subsection (1) is subject.\n\n(3) A licence is subject to such other conditions as are specified in the licence.\n\n(4) The conditions specified in the licence may include, but are not limited to, conditions relating to the following—\n\n(a) the persons authorised by the licence to use excess ART embryos or human eggs, or create or use other embryos;\n\n(b) the number of excess ART embryos or human eggs authorised to be used under the licence, or the number of other embryos authorised to be created or used under the licence;\n\n(c) reporting;\n\n(d) monitoring;\n\n(e) information to be given by the licence holder to persons authorised by the licence to use excess ART embryos or human eggs, or to create or use other embryos.\n\n(5) The licence conditions set out in subsections (1), (2) and (3) apply to all persons who are authorised by the licence to use excess ART embryos or human eggs, or to create or use other embryos.\n\n(6) Licence conditions specified in the licence apply to—\n\n(a) the licence holder; and\n\n(b) such other persons authorised by the licence to use excess ART embryos or human eggs, or to create or use other embryos, as are specified in the licence.\n\n(7) For the purposes of applying the condition referred to in subsection (1)(a)—\n\n(a) a licence may provide that the guidelines referred to in the definition of ***proper consent*** apply in a modified form in relation to the use, under the licence, of excess ART embryos that are unsuitable for implantation; and\n\n(b) if a licence so provides, the guidelines as modified by the licence have effect in relation to the giving of consent for such creation or use.\n\n**Example**\n\nThe guidelines could apply to a particular licence in a modified form, to alter the cooling-off period required in relation to the use of excess ART embryos that are unsuitable for implantation.\n\n\t19 Variation of licence\n\n(1) The NHMRC Licensing Committee may, by notice in writing given to the licence holder, vary a licence if the Committee believes on reasonable grounds that it is necessary or desirable to do so.\n\n(2) The NHMRC Licensing Committee may vary a licence under subsection (1) on its own initiative or on application by the licence holder.\n\n(3) Without limiting subsection (1), the NHMRC Licensing Committee may vary the licence by specifying additional conditions or varying existing conditions.\n\n(4) The NHMRC Licensing Committee must not vary a licence in such a way that, had a person applied under section 14 for the licence as varied, the Committee would not have been permitted by this Act to issue the licence.\n\n\t20 Suspension or revocation of licence\n\n(1) The NHMRC Licensing Committee may, by notice in writing given to the licence holder, suspend or revoke a licence if the Committee believes on reasonable grounds that a condition of the licence has been breached.\n\n(2) If a licence holder is convicted of an offence under this Act or the **Prohibition of Human Cloning for Reproduction Act 2008** or under the Commonwealth Act or the Prohibition of Human Cloning Act 2002 of the Commonwealth, the NHMRC Licensing Committee must, by notice in writing given to the licence holder, revoke each licence held by the licence holder.\n\n\t21 Surrender of licence\n\nA licence holder may surrender a licence by written notice given to the NHMRC Licensing Committee.\n\n\t22 Notification of variation, suspension or revocation of licence\n\n(1) If the NHMRC Licensing Committee varies, suspends or revokes a licence, the Committee must notify—\n\n(a) the licence holder; and\n\n(b) the HREC; and\n\n(c) the Authority.\n\n(2) The NHMRC Licensing Committee must also notify the HREC and the Authority if a licence is surrendered.\n\nDivision 3—Reporting and confidentiality\n\n\t23 NHMRC Licensing Committee to make certain information publicly available\n\n(1) The NHMRC Licensing Committee must maintain a database containing the following information in relation to each licence (including a licence as varied)—\n\n(a) the name of the person to whom the licence was issued;\n\n(b) a short statement about the nature of the uses of excess ART embryos or human eggs, and creations or uses of any other embryos, that are authorised by the licence;\n\n(c) any conditions to which the licence is subject;\n\n(d) the number of excess ART embryos or human eggs authorised to be used under the licence, or the number of other embryos authorised to be created or used under the licence;\n\n(e) the date on which the licence was issued;\n\n(f) the period throughout which the licence is to remain in force.\n\n(2) The database is to be made publicly available.\n\n(3) The database may be kept and made publicly available in electronic form.\n\n(4) Information mentioned in subsection (1) must not be such as to disclose confidential commercial information.\n\n\t24 Confidential commercial information may only be disclosed in certain circumstances\n\n(1) A person commits an offence if—\n\n(a) the person discloses confidential commercial information that the person has only because of performing duties or functions under this Act or the Commonwealth Act; and\n\n(b) the person knows that the information is confidential commercial information; and\n\n(c) the disclosure is not—\n\n(i) to a State agency, the Commonwealth or a Commonwealth authority in the course of carrying out duties or functions under this Act or the Commonwealth Act; or\n\n(ii) by order of a court; or\n\n(iii) with the consent of each person to whom the information has a commercial or other value.\n\n(2) A person commits an offence if—\n\n(a) the person discloses confidential commercial information that the person has only because of a disclosure permitted under subsection (1) or this subsection; and\n\n(b) the person knows that the information is confidential commercial information; and\n\n(c) the disclosure is not—\n\n(i) to a State agency, the Commonwealth or a Commonwealth authority in the course of carrying out duties or functions under this Act or the Commonwealth Act; or\n\n(ii) by order of a court; or\n\n(iii) with the consent of each person to whom the information has a commercial or other value.\n\n(3) An offence against subsection (1) or (2) is punishable by imprisonment for a term not exceeding 2 years.\n\n(4) In this section—\n\n***court*** includes a tribunal, authority or person having power to require the production of documents or the answering of questions;\n\n***State agency*** means the following—\n\n(a) the Crown in right of the State;\n\n(b) a Minister of the State;\n\n(c) a State Government department;\n\n(d) the Authority or any other instrumentality of the State, including a body corporate established for a public purpose by or under a law of the State;\n\n(e) a company in which a controlling interest is held by any one of the following persons, or by 2 or more of the following persons together—\n\n(i) the Crown in right of the State;\n\n(ii) a person or body covered by paragraph (b) or (d);\n\n(iii) a person or body covered by either subparagraph (i) or (ii).\n\n**Note**\n\nFor the definition of ***confidential commercial information***, see section 3.\n\nDivision 4—Review provisions\n\n\t25 Meaning of terms\n\nIn this Division—\n\nS. 25 def. of *Administrative Appeals Tribunal* repealed by No. 41/2025 s. 3(Sch. 1 item 25.1(a)).\n\n* * * * *\n\nS. 25 def. of *Administrative Review Tribunal* inserted by No. 41/2025 s. 3(Sch. 1 item 25.1(b)).\n\n***Administrative Review Tribunal*** means the Administrative Review Tribunal established by the Administrative Review Tribunal Act 2024 of the Commonwealth;\n\nS. 25 def. of *decision* amended by No. 41/2025 s. 3(Sch. 1 item 25.1(c)).\n\n***decision*** has the same meaning as in the Administrative Review Tribunal Act 2024 of the Commonwealth;\n\n***eligible person***, in relation to a decision of the NHMRC Licensing Committee, means—\n\n(a) in relation to a decision under section 15 not to issue a licence—the applicant for the licence; or\n\n(b) in relation to a decision in respect of the period throughout which the licence is to be in force under section 17—the licence holder; or\n\n(c) in relation to a decision to specify a licence condition under section 18(4)—the licence holder; or\n\n(d) in relation to a decision to modify guidelines under section 18(7) in respect of a licence—the licence holder; or\n\n(e) in relation to a decision to vary or refuse to vary a licence under section 19—the licence holder; or\n\n(f) in relation to a decision to suspend or revoke a licence under section 20—the person who was the licence holder immediately before the suspension or revocation.\n\n\t26 Review of decisions\n\nS. 26(1) amended by No. 41/2025 s. 3(Sch. 1 item 25.2).\n\n(1) An eligible person may apply to the Administrative Review Tribunal for review of the following decisions of the NHMRC Licensing Committee—\n\n(a) a decision under section 15 not to issue a licence;\n\n(b) a decision in respect of the period throughout which the licence is to be in force under section 17;\n\n(c) a decision to specify a licence condition under section 18(4);\n\n(d) a decision to modify guidelines under section 18(7) in respect of a licence;\n\n(e) a decision to vary or refuse to vary a licence under section 19;\n\n(f) a decision to suspend or revoke a licence under section 20.\n\nS. 26(2) amended by No. 41/2025 s. 3(Sch. 1 item 25.3).\n\n(2) This section has effect subject to the Administrative Review Tribunal Act 2024 of the Commonwealth.\n\nPart 4—Monitoring powers\n\n\t27 Powers available to inspectors for monitoring compliance\n\n(1) For the purpose of finding out whether this Act or the regulations made for the purposes of this Act have been complied with, an inspector may—\n\n(a) enter any premises; and\n\n(b) exercise the monitoring powers set out in section 28.\n\n(2) An inspector is not authorised to enter premises under subsection (1) unless—\n\n(a) the occupier of the premises has consented to the entry; or\n\n(b) the premises are premises at which the occupier of the premises is carrying out activities authorised by a licence issued under section 15, and the entry is at a reasonable time; or\n\n(c) the entry is made under a warrant under section 30.\n\n\t28 Monitoring powers\n\n(1) The monitoring powers that an inspector may exercise under section 27(1)(b) are as follows—\n\n(a) to search the premises and any thing on the premises;\n\n(b) to inspect, examine, take measurements of, conduct tests on, or take samples of, any human embryo, other embryo, human egg or thing on the premises that relates to this Act;\n\n(c) to take photographs, make video or audio recordings or make sketches of the premises or any thing on the premises;\n\n(d) to inspect any book, record or document on the premises;\n\n(e) to take extracts from or make copies of any such book, record or document;\n\n(f) to take onto the premises such equipment and materials as the inspector requires for the purpose of exercising powers in relation to the premises;\n\n(g) in addition to the powers mentioned in paragraphs (a) to (f), if the inspector was authorised to enter the premises by a warrant under section 30—to require any person in or on the premises to—\n\n(i) answer any questions put by the inspector; and\n\n(ii) produce any book, record or document requested by the inspector.\n\n(2) For the purposes of this Act, monitoring powers include the power to operate equipment at premises to see whether—\n\n(a) the equipment; or\n\n(b) a disk, tape or other storage device that—\n\n(i) is at the premises; and\n\n(ii) can be used with the equipment or is associated with it—\n\ncontains information that is relevant to determining whether there has been compliance with this Act or the regulations made for the purposes of this Act.\n\n(3) If the inspector, after operating equipment at the premises, finds that the equipment, or that a tape, disk or other storage device at the premises, contains information mentioned in subsection (2), the inspector may—\n\n(a) operate equipment or facilities at the premises to put the information in documentary form and copy the document so produced; or\n\n(b) if the information can be transferred to a tape, disk or other storage device that—\n\n(i) is brought to the premises; or\n\n(ii) is at the premises and the use of which has been agreed to in writing by the occupier of the premises—\n\noperate the equipment or other facilities to copy the information to the storage device, and remove the storage device from the premises.\n\n\t29 Power to secure\n\nIf an inspector, during a search of premises, believes on reasonable grounds that there is at the premises a human embryo, another embryo, a human egg or a thing that may afford evidence of the commission of an offence against this Part, the monitoring powers include securing the embryo, the egg or thing pending the obtaining of a warrant (whether by the inspector or by another person) to seize it.\n\n\t30 Monitoring warrants\n\n(1) An inspector may apply to a magistrate for the issue of a warrant under this section in relation to premises.\n\nS. 30(2) amended by No. 6/2018 s. 68(Sch. 2 item 108).\n\n(2) Subject to subsection (3), the magistrate may issue the warrant if the magistrate is satisfied by evidence on oath or by affirmation or by affidavit that it is reasonably necessary that one or more inspectors should have access to the premises for the purposes of finding out whether this Act or the regulations made for the purposes of this Act have been complied with.\n\n(3) The magistrate must not issue the warrant unless the inspector or some other person has given to the magistrate, either orally or by affidavit, such further information (if any) as the magistrate requires concerning the grounds on which the issue of the warrant is being sought.\n\n(4) The warrant must—\n\n(a) authorise one or more inspectors (whether or not named in the warrant) with such assistance and by such force as is necessary and reasonable—\n\n(i) to enter the premises; and\n\n(ii) to exercise the powers set out in section 28 in relation to the premises; and\n\n(b) state whether the entry is authorised to be made at any time of the day or night or during specified hours of the day or night; and\n\n(c) specify the day (not more than 15 days after the issue of the warrant) on which the warrant ceases to have effect; and\n\n(d) state the purpose for which the warrant is issued.\n\n(5) Except as provided by this Act, the rules to be observed with respect to search warrants under the **Magistrates' Court Act 1989** extend and apply to warrants under this section.\n\n\t31 Details of warrant to be given to occupier etc.\n\n(1) If a warrant under section 30 is being executed and the occupier of the premises, or another person who apparently represents the occupier, is present at the premises, the inspector must make available to that person a copy of the warrant.\n\n(2) The inspector must identify himself or herself to that person.\n\n(3) The copy of the warrant referred to in subsection (1) need not include the signature of the magistrate who issued the warrant.\n\n\t32 Announcement before entry\n\nAn inspector must, before entering premises under a warrant—\n\n(a) announce that he or she is authorised to enter the premises; and\n\n(b) give any person at the premises an opportunity to allow entry to the premises.\n\n\t33 Occupier entitled to be present during search\n\n(1) If a warrant under section 30 is being executed and the occupier of the premises, or another person who apparently represents the occupier, is present at the premises, the person is entitled to observe the search being conducted.\n\n(2) The right to observe the search being conducted ceases if the person impedes the search.\n\n(3) This section does not prevent 2 or more areas of the premises being searched at the same time.\n\n\t34 Inspector must produce identity card on request\n\n(1) An inspector is not entitled to exercise any powers under this Act in relation to premises if—\n\n(a) the occupier of the premises has required the inspector to produce his or her identity card for inspection by the occupier; and\n\n(b) the inspector fails to comply with the requirement.\n\n(2) In this section ***identity card*** means identity card issued under section 34(1) of the Commonwealth Act.\n\n\t35 Consent\n\n(1) Before obtaining the consent of a person for the purposes of section 27(2)(a), the inspector must inform the person that he or she may refuse consent.\n\n(2) An entry of an inspector by virtue of the consent of a person is not lawful unless the person voluntarily consented to the entry.\n\n\t36 Compensation for damage\n\n(1) The owner of equipment or other facilities is entitled to compensation for damage to the equipment or other facilities if—\n\n(a) the damage was caused to the equipment or other facilities as a result of it being operated by an inspector as mentioned in this Act; and\n\n(b) the damage was caused as a result of insufficient care being exercised by the inspector operating the equipment or other facilities.\n\n(2) Compensation is payable by the NHMRC Licensing Committee.\n\n(3) In determining the amount of compensation payable, regard is to be had to whether the occupier of the premises and the occupier's employees and agents, if they were available at the time, had provided any warning or guidance as to the operation of the equipment or other facilities that was appropriate in the circumstances.\n\n\t37 Extended operation of this Part\n\nA reference in this Part to this Act includes a reference to the **Prohibition of Human Cloning for Reproduction Act 2008**, and a reference in this Part to the regulations includes a reference to the regulations made under the **Prohibition of Human Cloning for Reproduction Act 2008**.\n\nPart 5—General\n\n\t38 Regulations\n\nThe Governor in Council may make regulations prescribing matters—\n\n(a) required or permitted by this Act to be prescribed; or\n\n(b) necessary or convenient to be prescribed for carrying out or giving effect to this Act.\n\nPart 6—Transitional provisions and consequential amendment to other Acts\n\n\tDivision 1—Transitional provisions\n\n\t39 Definitions\n\nIn this Division—\n\n***commencement*** means the commencement of this Act;\n\n***repealed Act*** means the **Infertility Treatment Act 1995**.\n\n\t40 Superseded references\n\nOn and from the commencement, a reference in an Act (other than this Act) or a document to Part 2A of the repealed Act is taken, if the context permits, to be a reference to this Act.\n\n\t41 Existing applications for licences\n\n(1) This section applies if—\n\n(a) before the commencement a person had applied for a licence under section 21H of the repealed Act; and\n\n(b) immediately before the commencement, the NHMRC Licensing Committee had not decided the application.\n\n(2) On and from the commencement, the application is to be decided under this Act as if it had been made after the commencement.\n\n\t42 Existing licences\n\n(1) This section applies to a licence issued under section 21I of the repealed Act that was in force immediately before the commencement.\n\n(2) On and from the commencement, the licence continues in force, on the terms and conditions that applied to the licence immediately before the commencement, as if it were a licence issued under this Act.\n\n\t43 Offences\n\nIf, immediately before the commencement, proceedings for an offence against Part 2A of the repealed Act had started but had not yet been determined, the proceedings may continue under the repealed Act as if that Act had not been repealed.\n\n\t44 Consent\n\n(1) This section applies if—\n\n(a) under the repealed Act a person had consented to the use of human sperm, an oocyte or a human embryo for research purposes; and\n\n(b) immediately before the commencement, the consent had not been withdrawn or lapsed.\n\n(2) On and from the commencement, the consent is taken to be a consent given for the purposes of this Act.\n\n\t45 Donations\n\n(1) This section applies, if immediately before the commencement, human sperm, an oocyte or a human embryo donated for the purposes of research under the repealed Act has not been used for that purpose.\n\n(2) On and from the commencement, the sperm, oocyte or embryo is taken to have been donated for the purposes of research under this Act.\n\nPt 6 Div. 2 (Heading and s. 46) repealed by No. 70/2013 s. 3(Sch. 1 item 46).\n\n* * * * *\n\n\n\nEndnotes\n\n1 General information\n\nSee [www.legislation.vic.gov.au](http://www.legislation.vic.gov.au) for Victorian Bills, Acts and current Versions of legislation and up-to-date legislative information.\n\n *Minister's second reading speech—*\n\n *Legislative Assembly: 10 September 2008*\n\n *Legislative Council: 10 October 2008*\n\nThe long title for the Bill for this Act was \"A Bill for an Act to regulate certain activities involving the use of human embryos, and for related purposes.\"\n\nThe **Research Involving Human Embryos Act 2008** was assented to on 25 November 2008 and came into operation on 1 January 2010: section 2(2).\n\nINTERPRETATION OF LEGISLATION ACT 1984 (ILA)\n\nStyle changes\n\nSection 54A of the ILA authorises the making of the style changes set out in Schedule 1 to that Act.\n\nReferences to ILA s. 39B\n\nSidenotes which cite ILA s. 39B refer to section 39B of the ILA which provides that where an undivided section or clause of a Schedule is amended by the insertion of one or more subsections or subclauses, the original section or clause becomes subsection or subclause (1) and is amended by the insertion of the expression \"(1)\" at the beginning of the original section or clause.\n\nInterpretation\n\nAs from 1 January 2001, amendments to section 36 of the ILA have the following effects:\n\n• Headings\n\nAll headings included in an Act which is passed on or after 1 January 2001 form part of that Act. Any heading inserted in an Act which was passed before 1 January 2001, by an Act passed on or after 1 January 2001, forms part of that Act. This includes headings to Parts, Divisions or Subdivisions in a Schedule; sections; clauses; items; tables; columns; examples; diagrams; notes or forms. See section 36(1A)(2A).\n\n• Examples, diagrams or notes\n\nAll examples, diagrams or notes included in an Act which is passed on or after 1 January 2001 form part of that Act. Any examples, diagrams or notes inserted in an Act which was passed before 1 January 2001, by an Act passed on or after 1 January 2001, form part of that Act. See section 36(3A).\n\n• Punctuation\n\nAll punctuation included in an Act which is passed on or after 1 January 2001 forms part of that Act. Any punctuation inserted in an Act which was passed before 1 January 2001, by an Act passed on or after 1 January 2001, forms part of that Act. See section 36(3B).\n\n• Provision numbers\n\nAll provision numbers included in an Act form part of that Act, whether inserted in the Act before, on or after 1 January 2001. Provision numbers include section numbers, subsection numbers, paragraphs and subparagraphs. See section 36(3C).\n\n• Location of \"legislative items\"\n\nA \"legislative item\" is a penalty, an example or a note. As from 13 October 2004, a legislative item relating to a provision of an Act is taken to be at the foot of that provision even if it is preceded or followed by another legislative item that relates to that provision. For example, if a penalty at the foot of a provision is followed by a note, both of these legislative items will be regarded as being at the foot of that provision. See section 36B.\n\n• Other material\n\nAny explanatory memorandum, table of provisions, endnotes, index and other material printed after the Endnotes does not form part of an Act.  \nSee section 36(3)(3D)(3E).\n\n2 Table of Amendments\n\nThis publication incorporates amendments made to the **Research Involving Human Embryos Act 2008** by Acts and subordinate instruments.\n\n–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––\n\n**Criminal Procedure Amendment (Consequential and Transitional Provisions) Act 2009, No. 68/2009**\n\n| Assent Date: | 24.11.09 |\n| --- | --- |\n| Commencement Date: | S. 97(Sch. item 102) on 1.1.10: Government Gazette 10.12.09 p. 3215 |\n| Current State: | This information relates only to the provision/s amending the **Research Involving Human Embryos Act 2008** |\n\n\n**Statute Law Revision Act 2013, No. 70/2013**\n\n| Assent Date: | 19.11.13 |\n| --- | --- |\n| Commencement Date: | S. 3(Sch. 1 item 46) on 1.12.13: s. 2(1) |\n| Current State: | This information relates only to the provision/s amending the **Research Involving Human Embryos Act 2008** |\n\n\n**Oaths and Affirmations Act 2018, No. 6/2018**\n\n| Assent Date: | 27.2.18 |\n| --- | --- |\n| Commencement Date: | S. 68(Sch. 2 item 108) on 1.3.19: s. 2(2) |\n| Current State: | This information relates only to the provision/s amending the **Research Involving Human Embryos Act 2008** |\n\n\n**Statute Law Revision Act 2025, No. 41/2025**\n\n| Assent Date: | 21.10.25 |\n| --- | --- |\n| Commencement Date: | S. 3(Sch. 1 item 25) on 22.10.25: s. 2 |\n| Current State: | This information relates only to the provision/s amending the **Research Involving Human Embryos Act 2008** |\n\n\n–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––\n\n3 Explanatory details\n\nNo entries at date of publication.","sortOrder":0}],"analysis":{"summary":{"complexity_score":6,"scope_assessment":{"changed":false,"description":"Based on the available metadata, there is no clear indication that the scope of the Act changed from its original intent. The Act as made and the consolidated version appear consistent, though the limited text provided prevents a definitive assessment of any amendments that may have altered scope over time."},"complexity_factors":["Operates in conjunction with Commonwealth legislation, requiring understanding of federal-state interplay","Involves highly technical scientific concepts (embryology, IVF, genetic research) that require specialist knowledge to interpret","Raises complex ethical and philosophical questions about the legal status of human embryos that inform interpretation","Licensing regime likely involves multiple regulatory bodies and bureaucratic processes","Significant criminal penalties typically attached to breaches, raising high stakes for compliance","Limited legislative text provided in the source material, making full analysis difficult — actual Act likely contains numerous detailed definitions and prohibitions adding further complexity"],"plain_english_summary":"## Research Involving Human Embryos Act 2008 (Victoria)\n\nThis Victorian law **regulates scientific research that uses human embryos**. It sets out the rules for when researchers can legally use human embryos in their work, and what safeguards must be in place to protect against misuse.\n\n**Who does this affect?**\n- Scientists and medical researchers working with human embryos\n- Fertility clinics and IVF (in vitro fertilisation — where eggs are fertilised outside the body) providers\n- Research institutions and universities conducting embryo-related studies\n- Couples who have donated surplus IVF embryos for research\n\n**Why does it matter?**\nHuman embryo research is a sensitive area touching on ethical, moral, and scientific concerns. This law tries to balance **advancing medical knowledge** (such as research into genetic diseases or improving IVF success rates) with **protecting human embryos** from exploitation or unethical use.\n\nThe Act mirrors national legislation (the Commonwealth's *Research Involving Human Embryos Act 2002*) to create a consistent framework across Australia. It requires researchers to obtain **licences** (official government permission) before conducting embryo research, and sets strict penalties for breaches.\n\n**Note:** The available text is largely structural/metadata only, so a full detailed breakdown of every specific provision is not possible from this extract alone."},"kimi_summary":{"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"The legislation appears to maintain its original scope as enacted in 2008. The amendments shown in the endnotes are minor administrative updates: updating references to the Criminal Procedure Act (2009), removing spent provisions (2013), updating oath/affirmation procedures (2018), and replacing references to the Administrative Appeals Tribunal with the new Administrative Review Tribunal (2025). These are machinery amendments that do not expand the substantive scope beyond the original purpose of regulating embryo research through a licensing system."},"complexity_factors":["Extensive defined terms section (section 3) with 25+ specialised definitions including technical biological terms like 'precursor cells', 'mitotic division', and 'primitive streak'","Complex nested exceptions structure in section 6(3) with 6 different categories of 'exempt use' that operate as defences to criminal offences","Cross-referencing with Commonwealth legislation (Research Involving Human Embryos Act 2002, NHMRC Act 1992) requiring simultaneous reading of federal and state law","Multiple overlapping offence provisions (sections 6-10) with similar penalty structures but subtly different elements and exceptions","Conditional licensing framework with mandatory conditions (section 18), discretionary conditions (section 18(4)), and modification powers (section 18(7))","Administrative law components including reviewable decisions (section 26), notification requirements (sections 16, 22), and database maintenance (section 23)","Transitional provisions (Part 6) preserving rights and liabilities from the repealed Infertility Treatment Act 1995","Monitoring powers (Part 4) incorporating warrant procedures, consent requirements, and compensation provisions with detailed procedural safeguards"],"plain_english_summary":"**What this law does:**\n\nThis Act regulates scientific research involving human embryos in Victoria. It creates a licensing system that allows certain types of embryo research to occur legally, while criminalising unauthorised activities. The law aims to balance scientific advancement with ethical concerns about human reproduction and embryo use.\n\n**Who it affects:**\n\n- **Scientists and researchers** wanting to conduct embryo research\n- **Fertility clinics** (accredited ART centres) handling excess embryos\n- **Patients** who have undergone fertility treatment and have leftover embryos\n- **The NHMRC Licensing Committee** (a federal body that issues licences)\n- **Inspectors** who monitor compliance\n\n**Key rules:**\n\n- **You generally cannot use human embryos for research without a licence.** Doing so carries penalties of up to 5 years in prison.\n- **\"Excess ART embryos\"** (leftover embryos from IVF that are no longer needed by the people who created them) can be used for research, but only with proper consent from all \"responsible persons\" (the biological parents and their partners) and only under a licence.\n- **Some activities are completely banned** unless licensed, including:\n  - Creating embryos without using sperm and egg (e.g., cloning techniques)\n  - Creating embryos with genetic material from more than two people\n  - Creating \"hybrid embryos\" (mixing human and animal genetic material)\n  - Using precursor cells from embryos or foetuses to create new embryos\n- **Research on eggs and sperm** up to the point of fertilisation also requires a licence.\n\n**The licensing system:**\n\n- Applications go to the NHMRC Licensing Committee (a federal committee)\n- Licences can specify conditions like how many embryos can be used, who can do the research, and reporting requirements\n- Licences can be varied, suspended, or revoked if conditions are breached\n- Decisions can be reviewed by the Administrative Review Tribunal\n\n**Monitoring and enforcement:**\n\n- Inspectors can enter premises (with consent, warrant, or at reasonable times for licensed facilities) to check compliance\n- They can examine records, take samples, photograph equipment, and secure evidence\n- There are strict rules protecting **confidential commercial information**\n\n**Why it matters:**\n\nThis law sits at the intersection of medical science, ethics, and human rights. It allows Victoria to participate in cutting-edge stem cell research and fertility science while maintaining strict ethical boundaries. It ensures that embryos—whether leftover from IVF or created specifically for research—are only used with proper consent and oversight, preventing unauthorised experimentation or reproductive cloning."},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":true,"description":"The version provided incorporates procedural and administrative amendments since enactment that alter review and evidence procedures without changing the core prohibitions and licensing scheme. Notable changes recorded in the Table of Amendments include:\n\n- Adjustment to evidentiary/burden provisions in s.6(4) (amended by Criminal Procedure Amendment Act 2009), affecting the accused's evidential burden in certain defences (see Table of Amendments entry for No. 68/2009).\n- Amendment to warrant evidence language in s.30(2) (Oaths and Affirmations Act 2018) permitting oath, affirmation or affidavit as the basis for warrant issuance (see Table of Amendments entry for No. 6/2018).\n- Substitution of review body references in s.25 and consequential updates to s.26 to refer to the Administrative Review Tribunal (Statute Law Revision Act 2025), changing the administrative review pathway without removing review rights (see Table of Amendments entry for No. 41/2025; s.25–26).\n- Repeal of a transitional subdivision (Pt 6 Div 2) by Statute Law Revision Act 2013 (see Table of Amendments entry for No. 70/2013).\n\nThese amendments chiefly modify administrative procedure, evidence and review pathways while the Act's substantive scope—criminal offences, licence requirements, consent protocol, 14‑day development cap and monitoring powers—remains in place (see s.6–20, s.14(2), s.27–31)."},"complexity_factors":["Technical biomedical definitions (human embryo, hybrid embryo, precursor cell, excess ART embryo) and precise temporal limit (14 days) (s.3–4, s.14(2)).","Criminal offence structure with high-penalty indictable offences and nuanced exceptions (s.6–11).","Cross-jurisdictional references and reliance on Commonwealth instruments and NHMRC guidelines (definitions and proper consent) requiring coordination with Commonwealth Act and NHMRC rules (s.3, references to Commonwealth Act and NHMRC).","Detailed licensing regime with discretionary decision-making by the NHMRC Licensing Committee, multiple licence conditions and reporting requirements (s.12–20, s.18).","Mandatory HREC assessment and compliance with NHMRC National Statement and guidelines, introducing procedural prerequisites external to the Act (s.15(3)(b), s.15(4)(c)).","Comprehensive monitoring powers for inspectors including search, seizure, data access and warrant procedures, with statutory safeguards and compensation rules (s.27–36).","Confidentiality carve-outs and separate criminal offence for improper disclosure of confidential commercial information (s.23–24).","Transitional and amendment history that changes procedural elements (administrative review body, evidentiary/formal requirements), creating layered interpretation issues (endnotes/Table of Amendments; s.25–26, amendment notes)."],"plain_english_summary":"### What this law does, who it affects, and how it works\n\n- Mechanically, the Act creates criminal offences, a licence system and monitoring powers to regulate research and other activities that involve human embryos (defined in detail) and certain human eggs. It also sets rules about consent, reporting and confidentiality. (See Parts 1–5: definitions at s.3–4; offences at s.6–11; licences at s.12–22; monitoring at s.27–37; reporting/confidentiality at s.23–24.)\n\n- Who it affects\n  - Researchers and institutions that want to use or create embryos for research (they must apply for licences held by the NHMRC Licensing Committee). (s.12–15)\n  - Accredited ART centres and fertility clinics (they have limited exemptions but also must comply with licence and consent requirements). (s.6(3)(d)–(e), s.14(1)(f))\n  - People who provided the reproductive material or are otherwise a \"responsible person\" for an embryo — their proper consent is required before use. (Definitions and s.18(1))\n  - Inspectors and regulators who monitor compliance and maintain a public licence database. (s.23, s.27–31)\n\n- Main legal mechanics\n  - Criminal offences: Intentionally using an \"excess ART embryo\" or certain other embryos without a licence is an indictable offence with penalties up to 5 years' imprisonment (s.6–11). Specific prohibited activities are listed (e.g. use of embryos created by non‑standard processes, use of eggs up to first mitotic division for ART research without a licence). (s.6–9)\n  - Licensing: The NHMRC Licensing Committee decides licence applications (s.12–15). A licence authorises specific activities (listed in s.14) but may not allow embryo development beyond 14 days (s.14(2)). Before issuing a licence the Committee must be satisfied that consent protocols and Human Research Ethics Committee (HREC) approval are in place (s.15(3)). Licences carry conditions (consent reporting, limits on numbers, reporting, monitoring) and can be varied, suspended or revoked by the Committee (s.18–20). Licence applicants must follow NHMRC guidelines and may pay a prescribed fee (s.14(3)(b), s.15(4)(c), s.18).\n  - Consent and reporting: A licence condition requires that every \"responsible person\" has given \"proper consent\" (as defined by NHMRC guidelines) and that the licence holder must report that consent and any restrictions to the NHMRC Licensing Committee before using the embryo or egg. (s.18(1)–(2))\n  - Transparency and confidentiality: The NHMRC Licensing Committee must keep a publicly available database of licence details (name, authorised uses, conditions, number authorised, dates) but must not disclose confidential commercial information. Unauthorized disclosure of such confidential commercial information is a separate offence (s.23–24).\n  - Monitoring and enforcement: Inspectors can enter premises with consent or a warrant, inspect and copy records, operate equipment to access relevant data, take samples or secure possible evidence, and, with a warrant, require persons to answer questions and produce documents. Warrants are issued by a magistrate on oath/affidavit/affirmation (s.27–36, s.30). Compensation rules apply for damage to equipment caused by inspectors' inadequate care (s.36).\n  - Review and transition: Eligible persons may seek review of certain Committee decisions (refusal to issue, conditions, variation, suspension or revocation) through the Administrative Review Tribunal as provided (s.25–26). Transitional provisions carry over certain existing licences and consents from the repealed Infertility Treatment Act 1995 (s.39–45).\n\n- Official rationale claimed in the Act\n  - The Act states its purpose is to address concerns, including ethical concerns, arising from scientific developments in human reproduction and embryo use by regulating relevant activities (s.1).\n\n- Testing that purpose against practical mechanics, incentives and trade-offs (source‑grounded)\n  - Who pays: Licence applicants pay any prescribed fee to apply (s.14(3)(b)). The NHMRC Licensing Committee bears administrative costs of processing, maintaining a public database and enforcing conditions (s.12–13, s.23). Inspectors operate under the Committee and compensation for damage to equipment is payable by the NHMRC Licensing Committee (s.36(2)).\n  - Who decides and where discretion lies: The NHMRC Licensing Committee has broad authority to decide whether to issue licences, to set and vary conditions, and to suspend or revoke licences (s.15, s.18–20). The Committee must be satisfied about consent protocols and HREC approval (s.15(3)) but otherwise has evaluative discretion (s.15(4)). A magistrate decides on issue of monitoring warrants based on sworn information (s.30). These arrangements concentrate decision-making authority in the NHMRC Licensing Committee and magistrates (s.12–15, s.30).\n  - Compliance burden and administrative cost: Applicants must secure HREC assessment in line with NHMRC standards and implement protocols to obtain and document proper consent (s.15(3)(b), s.18(1)). Licence conditions commonly require limits on numbers, reporting and monitoring (s.18(4)(a)–(d)) and those conditions apply to all persons authorised by the licence (s.18(5)–(6)). Maintaining the public database adds reporting workload (s.23). These are recurring procedural requirements for researchers and institutions.\n  - Legal risk and sanctions: Criminal offences with up to 5 years' imprisonment apply for unauthorised uses and for breach of licence conditions (s.6–11). That risk applies to individuals and institutions carrying out embryo-related activities without a valid licence or in contravention of licence conditions (s.10). The Act shields persons acting under a purported licence from criminal responsibility if they reasonably could not have known it was invalid (s.11).\n  - Limits and constraints on private choice and enterprise: The Act limits certain research activities unless a licence is obtained (s.14–15) and caps embryo development at 14 days under licences (s.14(2)). Some activities by accredited ART centres are expressly exempted (storage, diagnostic investigations, using embryos for another woman with accreditation) but other research uses require a licence (s.6(3), s.14(1)(f)). These arrangements impose legal gates that private researchers and ART centres must navigate.\n  - Trade-offs and opportunity costs: The Act prioritises regulatory oversight, consent safeguards and ethical review (HREC) over unfettered research access (s.15(3)–(4), s.18). That oversight implies administrative costs (licence fees, HREC processes, reporting) and potential delay in research. The Act also empowers enforcement (inspectors and warrants) which requires administrative resources to operate (s.27–31). The Act provides exemptions for routine clinical ART activities, keeping some private clinical practice outside the licensing requirement where the law so specifies (s.6(3), s.14(1)(f)).\n  - Implementation and enforcement risk: Effective application depends on the NHMRC Licensing Committee’s exercise of its functions and on inspectors being able to obtain warrants and perform monitoring tasks properly (s.12–13, s.27–31). The Act supplies procedural safeguards (warrant requirements, opportunity to observe searches, identity cards, compensation for damage) but implementation requires trained personnel and systems for consent recording, reporting and database maintenance (s.31–36, s.36).\n\n- Concentrated benefits and diffuse costs (source‑grounded observation)\n  - Licences confer legally exclusive authorisations to particular researchers or institutions for specified embryo work (benefit concentrated on licence holders) (s.14–15, s.23). Compliance burdens (consent protocols, HREC review, reporting, monitoring exposure, criminal penalties for non-compliance) fall on all researchers and affected ART centres (diffuse cost) (s.15(3), s.18(1)–(4), s.6–11).\n\n- Key concrete constraints and limits to note\n  - Definition and limits: \"Excess ART embryo\" is narrowly defined and consent by all responsible persons is required before use (s.3, s.4, s.18(1)).\n  - Development time cap: licences cannot authorise development beyond 14 days (s.14(2)).\n  - Public transparency: a licence database must be published, but confidential commercial information must be withheld and its unauthorised disclosure is penalised (s.23–24).\n\nThis summary is based on the Act's text and the amendment notes in the publication (see Table of Amendments)."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/research-involving-human-embryos-act-2008","history":"/api/acts/research-involving-human-embryos-act-2008/history","analysis":"/api/acts/research-involving-human-embryos-act-2008/analysis","conflicts":"/api/acts/research-involving-human-embryos-act-2008/conflicts","importantCases":"/api/acts/research-involving-human-embryos-act-2008/important-cases","documents":"/api/acts/research-involving-human-embryos-act-2008/documents"}}